The significance of TROP2 expression in predicting BRAF mutations in papillary thyroid carcinoma

13Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Background: Trophoblast antigen 2 (TROP2) is a human trophoblast cell-surface glycoprotein that is overexpressed in several types of epithelial cancers, and is suggested to be associated with an unfavorable prognosis. BRAF mutations are the most common genetic alteration in papillary thyroid carcinoma (PTC). We evaluated the correlation between TROP2 expression and BRAF mutation in PTC. Methods: First, we carried out pyrosequencing for BRAF mutations and immunohistochemistry for TROP2 expression with a tissue microarray consisting of 52 PTC cases. Membranous staining in at least 5% of tumor cells was designated as positive staining and we analyzed the relationship between TROP2 expression and diverse clinicopathological factors, including BRAF mutation. Second, we tested TROP2 mRNA expression in three thyroid cancer cell lines with BRAF mutations (BCPAP, SNU790, and 8505C) and a normal thyroid cell line. Additionally, we checked TROP2 protein levels in a normal thyroid cell line after introduction of the BRAF V600E mutation. Results: In this study, 21 of 26 cases with BRAF mutation showed TROP2 immunoreactivity, whereas all 26 cases without BRAF mutation showed no immunoreactivity for TROP2 with a statistically significant difference (p < .001). Upregulation of TROP2 mRNA was observed in all three thyroid cancer cell lines, but not in the normal thyroid cell line. Interestingly, however, the TROP2 expression was increased in the normal thyroid cell line after introduction of the BRAF V600E mutation. Conclusions: Based on these results, we concluded that TROP2 expression is significantly associated with BRAF mutation and that TROP2 immunohistochemistry could be used for predicting BRAF mutations or diagnosing papillary thyroid carcinoma.

References Powered by Scopus

Global cancer statistics

31577Citations
N/AReaders
Get full text

Mutations of the BRAF gene in human cancer

9021Citations
N/AReaders
Get full text

BRAF mutation in thyroid cancer

1144Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Targeting trop-2 in solid tumors: Future prospects

114Citations
N/AReaders
Get full text

Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer

57Citations
N/AReaders
Get full text

TROP2 promotes cell proliferation and migration in osteosarcoma through PI3K/AKT signaling

33Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kong, J. S., Kim, H. J., Kim, M. J., Kim, A., Lee, D., Han, K., … Myung, J. K. (2018). The significance of TROP2 expression in predicting BRAF mutations in papillary thyroid carcinoma. Journal of Pathology and Translational Medicine, 52(1), 14–20. https://doi.org/10.4132/jptm.2017.10.17

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

63%

Researcher 2

25%

Professor / Associate Prof. 1

13%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

56%

Agricultural and Biological Sciences 2

22%

Biochemistry, Genetics and Molecular Bi... 1

11%

Social Sciences 1

11%

Save time finding and organizing research with Mendeley

Sign up for free